Ipsen S.A. (IPN.PA) has a MoatMap StockRank of 93/100 based on Quality (71/100), Value (40/100), and Momentum (65/100) factor scores. The current signal is STRONG BUY. Ipsen S.A., a French specialty pharmaceutical company focused on rare diseases and oncology, embodies the 'Specialty Pharma & Biotech Growth' theme with strong IP, high ROIC potential, clear market pathways, and durable moats, representing a defensive growth opportunity.